EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Natural History of Myocardial α v β 3 Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow

Matthieu Dietz, Christel H Kamani, Colin Bousige, Vincent Dunet, Judith Delage, Vladimir Rubimbura, Marie Nicod Lalonde, Giorgio Treglia, Niklaus Schaefer, Wail Nammas, Antti Saraste, Juhani Knuuti und 2 weitere

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267514 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Matthieu Dietz und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Integrin alphaVbeta3, Myocardial Infarction, Positron Emission Tomography Computed Tomography, Coronary Circulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is an essential part of the cardiac repair process after myocardial infarction, but its spatiotemporal dynamics remain to be fully deciphered.68Ga-NODAGA-Arg-Gly-Asp (RGD) is a PET tracer targeting αvβ3 integrin expression, which is a marker of angiogenesis.

Methods

In this prospective single-center trial, we aimed to monitor angiogenesis through myocardial integrin αvβ3 expression in 20 patients with ST-segment elevation myocardial infarction (STEMI). In addition, the correlations between the expression levels of myocardial αvβ3 integrin and the subsequent changes in 82Rb PET/CT parameters, including rest and stress myocardial blood flow (MBF), myocardial flow reserve (MFR), and wall motion abnormalities, were assessed. The patients underwent 68Ga-NODAGA-RGD PET/CT and rest and stress 82Rb-PET/CT at 1 wk, 1 mo, and 3 mo after STEMI. To assess 68Ga-NODAGA-RGD uptake, the summed rest 82Rb and 68Ga-NODAGA-RGD images were coregistered, and segmental SUVs were calculated (RGD SUV).

Results

At 1 wk after STEMI, 19 participants (95%) presented increased 68Ga-NODAGA-RGD uptake in the infarcted myocardium. Seventeen participants completed the full imaging series. The values of the RGD SUV in the infarcted myocardium were stable 1 mo after STEMI (1 wk vs. 1 mo, 1.47 g/mL [interquartile range (IQR), 1.37-1.64 g/mL] vs. 1.47 g/mL [IQR, 1.30-1.66 g/mL]; P = 0.9), followed by a significant partial decrease at 3 mo (1.32 g/mL [IQR, 1.12-1.71 g/mL]; P = 0.011 vs. 1 wk and 0.018 vs. 1 mo). In segment-based analysis, positive correlations were found between RGD SUV at 1 wk and the subsequent changes in stress MBF (Spearman ρ: r = 0.17, P = 0.0033) and MFR (Spearman ρ: r = 0.31, P < 0.0001) at 1 mo. A negative correlation was found between RGD SUV at 1 wk and the subsequent changes in wall motion abnormalities at 3 mo (Spearman ρ: r = -0.12, P = 0.035).

Conclusion

The present study found that αvβ3 integrin expression is significantly increased in the infarcted myocardium 1 wk after STEMI. This expression remains stable after 1 mo and partially decreases after 3 mo. Initial αvβ3 integrin expression at 1 wk is significantly weakly correlated with subsequent improvements in stress MBF, MFR, and wall motion analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Integrin alphaVbeta3Myocardial InfarctionPositron Emission Tomography Computed TomographyCoronary CirculationMyocardiumHumansMaleFemaleMiddle AgedAgedHeterocyclic Compounds, 1-RingProspective StudiesOligopeptidesRubidium RadioisotopesAcetates

Stichwörter der Autor:innen

PETRGDangiogenesisintegrin αvβ3myocardial infarction

Substanzen

Integrin alphaVbeta3Heterocyclic Compounds, 1-Ring1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononanearginyl-glycyl-aspartic acidOligopeptidesRubidium RadioisotopesAcetates

Autor:innen und Institutionen

  • Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital, Lausanne, Switzerland.
  • Institut de Cardiologie des Hospices Civils de Lyon, CarMeN Laboratory INSERM 1060, Université Claude Bernard Lyon 1, Lyon, France.
  • Service de Médecine Nucléaire, Hospices Civils de Lyon, Lyon, France.
  • Department of Cardiology, University Hospital of Lausanne, Lausanne, Switzerland.
  • Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • University of Lausanne, Lausanne, Switzerland.

Zitieren

APA

Dietz, M., Kamani, C. H., Bousige, C., Dunet, V., Delage, J., Rubimbura, V., Nicod Lalonde, M., Treglia, G., Schaefer, N., Nammas, W., Saraste, A., Knuuti, J., Mewton, N., & Prior, J. O. (2024). Natural History of Myocardial α v β 3 Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267514

Vancouver

Dietz M, Kamani CH, Bousige C, Dunet V, Delage J, Rubimbura V, et al. Natural History of Myocardial α v β 3 Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267514

BibTeX
@article{Dietz2024,
  author = {Dietz, Matthieu and Kamani, Christel H and Bousige, Colin and Dunet, Vincent and Delage, Judith and Rubimbura, Vladimir and Nicod Lalonde, Marie and Treglia, Giorgio and Schaefer, Niklaus and Nammas, Wail and Saraste, Antti and Knuuti, Juhani and Mewton, Nathan and Prior, John O},
  title = {Natural History of Myocardial α v β 3 Integrin Expression After Acute Myocardial Infarction: Correlation with Changes in Myocardial Blood Flow},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267514}
}
Kostenlos starten →